publication date: May. 5, 2017

Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”

Julie Izzo

Chair, Faculty Senate

Associate professor in Translational Molecular Pathology, MD Anderson Cancer Center.

Marshall E. Hicks, M.D., President ad Interim, The University of Texas MD Anderson Cancer Center, welcomed awardees of The President's Recognition for Faculty Excellence, which was held Tuesday night at the Frank E. Anderson Conference Hall on campus, Tuesday night, April 18, 2017.

 

MD Anderson, through its Shared Governance Committee,  is moving away from an “autocratic” structure, said Julie Izzo, chair of the Faculty Senate and an associate professor in Translational Molecular Pathology at MD Anderson Cancer Center.

Ronald DePinho, the fourth president of the Houston cancer hospital, resigned March 20 after leading the institution for over five years.

“You asked me what went wrong, and as I reflect, I think that culture matters. It matters a lot,” Izzo said to The Cancer Letter. “Over the past five years, we did have a clash of cultures, and it is important that there is an onboarding plan for the next president, and the onboarding plan must involve the MD Anderson community. That’s really necessary.”

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.